List of Tables
Table 1. Plasma-derived Therapies Market Trends
Table 2. Plasma-derived Therapies Market Drivers & Opportunity
Table 3. Plasma-derived Therapies Market Challenges
Table 4. Plasma-derived Therapies Market Restraints
Table 5. Global Plasma-derived Therapies Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Plasma-derived Therapies Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Plasma-derived Therapies Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Plasma-derived Therapies Product Type
Table 9. Key Companies Time to Begin Mass Production of Plasma-derived Therapies
Table 10. Global Plasma-derived Therapies Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma-derived Therapies as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Plasma-derived Therapies Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Plasma-derived Therapies Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Plasma-derived Therapies Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Plasma-derived Therapies Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Plasma-derived Therapies Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Plasma-derived Therapies Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Plasma-derived Therapies Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Plasma-derived Therapies Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Plasma-derived Therapies Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Plasma-derived Therapies Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Plasma-derived Therapies Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Plasma-derived Therapies Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Plasma-derived Therapies Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Plasma-derived Therapies Sales Value by Region (2019-2024) & (%)
Table 27. Global Plasma-derived Therapies Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Plasma-derived Therapies Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Plasma-derived Therapies Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Plasma-derived Therapies Sales Value, (2025-2030) & (US$ Million)
Table 31. CSL Behring LLC Basic Information List
Table 32. CSL Behring LLC Description and Business Overview
Table 33. CSL Behring LLC Plasma-derived Therapies Products, Services and Solutions
Table 34. Revenue (US$ Million) in Plasma-derived Therapies Business of CSL Behring LLC (2019-2024)
Table 35. CSL Behring LLC Recent Developments
Table 36. Shire Basic Information List
Table 37. Shire Description and Business Overview
Table 38. Shire Plasma-derived Therapies Products, Services and Solutions
Table 39. Revenue (US$ Million) in Plasma-derived Therapies Business of Shire (2019-2024)
Table 40. Shire Recent Developments
Table 41. Bayer Basic Information List
Table 42. Bayer Description and Business Overview
Table 43. Bayer Plasma-derived Therapies Products, Services and Solutions
Table 44. Revenue (US$ Million) in Plasma-derived Therapies Business of Bayer (2019-2024)
Table 45. Bayer Recent Developments
Table 46. Kedrion Basic Information List
Table 47. Kedrion Description and Business Overview
Table 48. Kedrion Plasma-derived Therapies Products, Services and Solutions
Table 49. Revenue (US$ Million) in Plasma-derived Therapies Business of Kedrion (2019-2024)
Table 50. Kedrion Recent Developments
Table 51. Takeda Basic Information List
Table 52. Takeda Description and Business Overview
Table 53. Takeda Plasma-derived Therapies Products, Services and Solutions
Table 54. Revenue (US$ Million) in Plasma-derived Therapies Business of Takeda (2019-2024)
Table 55. Takeda Recent Developments
Table 56. Biotest Basic Information List
Table 57. Biotest Description and Business Overview
Table 58. Biotest Plasma-derived Therapies Products, Services and Solutions
Table 59. Revenue (US$ Million) in Plasma-derived Therapies Business of Biotest (2019-2024)
Table 60. Biotest Recent Developments
Table 61. Octaparma Basic Information List
Table 62. Octaparma Description and Business Overview
Table 63. Octaparma Plasma-derived Therapies Products, Services and Solutions
Table 64. Revenue (US$ Million) in Plasma-derived Therapies Business of Octaparma (2019-2024)
Table 65. Octaparma Recent Developments
Table 66. Bio Products Laboratory (BPL) Basic Information List
Table 67. Bio Products Laboratory (BPL) Description and Business Overview
Table 68. Bio Products Laboratory (BPL) Plasma-derived Therapies Products, Services and Solutions
Table 69. Revenue (US$ Million) in Plasma-derived Therapies Business of Bio Products Laboratory (BPL) (2019-2024)
Table 70. Bio Products Laboratory (BPL) Recent Developments
Table 71. LFB Basic Information List
Table 72. LFB Description and Business Overview
Table 73. LFB Plasma-derived Therapies Products, Services and Solutions
Table 74. Revenue (US$ Million) in Plasma-derived Therapies Business of LFB (2019-2024)
Table 75. LFB Recent Developments
Table 76. Grifols Basic Information List
Table 77. Grifols Description and Business Overview
Table 78. Grifols Plasma-derived Therapies Products, Services and Solutions
Table 79. Revenue (US$ Million) in Plasma-derived Therapies Business of Grifols (2019-2024)
Table 80. Grifols Recent Developments
Table 81. Key Raw Materials Lists
Table 82. Raw Materials Key Suppliers Lists
Table 83. Plasma-derived Therapies Downstream Customers
Table 84. Plasma-derived Therapies Distributors List
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Plasma-derived Therapies Product Picture
Figure 2. Global Plasma-derived Therapies Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Plasma-derived Therapies Sales Value (2019-2030) & (US$ Million)
Figure 4. Plasma-derived Therapies Report Years Considered
Figure 5. Global Plasma-derived Therapies Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma-derived Therapies Revenue in 2023
Figure 7. Plasma-derived Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Albumin Picture
Figure 9. Immunoglobulin Picture
Figure 10. Factor VIII Picture
Figure 11. Others Picture
Figure 12. Global Plasma-derived Therapies Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Plasma-derived Therapies Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Hemophilia
Figure 15. Product Picture of Primary Immunodeficiencies (PIDs)
Figure 16. Product Picture of Idiopathic Thrombocytopenic Purpura (ITP)
Figure 17. Product Picture of COVID-19
Figure 18. Product Picture of Others
Figure 19. Global Plasma-derived Therapies Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Plasma-derived Therapies Sales Value Market Share by Application, 2023 & 2030
Figure 21. North America Plasma-derived Therapies Sales Value (2019-2030) & (US$ Million)
Figure 22. North America Plasma-derived Therapies Sales Value by Country (%), 2023 VS 2030
Figure 23. Europe Plasma-derived Therapies Sales Value (2019-2030) & (US$ Million)
Figure 24. Europe Plasma-derived Therapies Sales Value by Country (%), 2023 VS 2030
Figure 25. Asia Pacific Plasma-derived Therapies Sales Value (2019-2030) & (US$ Million)
Figure 26. Asia Pacific Plasma-derived Therapies Sales Value by Country (%), 2023 VS 2030
Figure 27. South America Plasma-derived Therapies Sales Value (2019-2030) & (US$ Million)
Figure 28. South America Plasma-derived Therapies Sales Value by Country (%), 2023 VS 2030
Figure 29. Middle East & Africa Plasma-derived Therapies Sales Value (2019-2030) & (US$ Million)
Figure 30. Middle East & Africa Plasma-derived Therapies Sales Value by Country (%), 2023 VS 2030
Figure 31. Key Countries/Regions Plasma-derived Therapies Sales Value (%), (2019-2030)
Figure 32. United States Plasma-derived Therapies Sales Value, (2019-2030) & (US$ Million)
Figure 33. United States Plasma-derived Therapies Sales Value by Type (%), 2023 VS 2030
Figure 34. United States Plasma-derived Therapies Sales Value by Application (%), 2023 VS 2030
Figure 35. Europe Plasma-derived Therapies Sales Value, (2019-2030) & (US$ Million)
Figure 36. Europe Plasma-derived Therapies Sales Value by Type (%), 2023 VS 2030
Figure 37. Europe Plasma-derived Therapies Sales Value by Application (%), 2023 VS 2030
Figure 38. China Plasma-derived Therapies Sales Value, (2019-2030) & (US$ Million)
Figure 39. China Plasma-derived Therapies Sales Value by Type (%), 2023 VS 2030
Figure 40. China Plasma-derived Therapies Sales Value by Application (%), 2023 VS 2030
Figure 41. Japan Plasma-derived Therapies Sales Value, (2019-2030) & (US$ Million)
Figure 42. Japan Plasma-derived Therapies Sales Value by Type (%), 2023 VS 2030
Figure 43. Japan Plasma-derived Therapies Sales Value by Application (%), 2023 VS 2030
Figure 44. South Korea Plasma-derived Therapies Sales Value, (2019-2030) & (US$ Million)
Figure 45. South Korea Plasma-derived Therapies Sales Value by Type (%), 2023 VS 2030
Figure 46. South Korea Plasma-derived Therapies Sales Value by Application (%), 2023 VS 2030
Figure 47. Southeast Asia Plasma-derived Therapies Sales Value, (2019-2030) & (US$ Million)
Figure 48. Southeast Asia Plasma-derived Therapies Sales Value by Type (%), 2023 VS 2030
Figure 49. Southeast Asia Plasma-derived Therapies Sales Value by Application (%), 2023 VS 2030
Figure 50. India Plasma-derived Therapies Sales Value, (2019-2030) & (US$ Million)
Figure 51. India Plasma-derived Therapies Sales Value by Type (%), 2023 VS 2030
Figure 52. India Plasma-derived Therapies Sales Value by Application (%), 2023 VS 2030
Figure 53. Plasma-derived Therapies Industrial Chain
Figure 54. Plasma-derived Therapies Manufacturing Cost Structure
Figure 55. Channels of Distribution (Direct Sales, and Distribution)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
